Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Your provider makes that determination after review
If GLP-1 analog drugs are being submitted as biosimilars, they also require a comparability assessment with the reference drug, including threshold evaluations and examination of parameters such as drug tolerance
The temporary program, running from July 2026 through December 2027, does not change the current statutory prohibition on Medicare coverage of drugs used for weight loss but instead is being established using the federal governments Section 402 demonstration authority
Research indicates the general population prevalence ranges from 13.8 to 267.7 per 100,000 adults [4]
US$ 28.87
US$ 23.04
US$ 23.76
US$ 24.14
US$ 21.01
US$ 24.83
US$ 24.77
US$ 20.04
